IEQ CAPITAL, LLC

Position in TAK — Takeda Pharmaceutical Co Ltd

CIK 1779789 Foster City, CA

Position in TAK

as of Mar 31, 2026 · filed May 15, 2026 Compact

Position Value

$1,931,932

+$511,528 QoQ

Shares Held

104,316

+14.5% QoQ

Ownership

0.003%

of shares outstanding

% of Portfolio

0.01%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Jun 2024

8 quarters on record

Voting authority Sole 22.71751217454657.ToString("F0")% Shared 0.ToString("F0")% None 77.28248782545343.ToString("F0")%

Healthcare · as of Mar 31, 2026

IEQ CAPITAL, LLC holds $139,775,851 across 17 Drug Manufacturers - Specialty & Generic names. TAK ranks #6 (1.4% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	NBIX	Neurocrine Biosciences Inc	765,982	$100,910,468
2	UTHR	UNITED THERAPEUTICS Corp	35,915	$21,296,876
3	ZTS	Zoetis Inc.	31,568	$3,731,652
4	IRWD	Ironwood Pharmaceuticals Inc	742,723	$2,606,957
5	KNSA	Kiniksa Pharmaceuticals International, plc	42,950	$2,068,042
6	TAK	Takeda Pharmaceutical Co Ltd This page	104,316	$1,931,932
7	RDY	Dr Reddys Laboratories Ltd	130,069	$1,801,455
8	TEVA	Teva Pharmaceutical Industries Ltd	42,533	$1,281,093

8 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$1,931,932	104,316	+14.5%	Shares	Other	2026-05-15
2025-12-31	$1,420,404	91,110	+3.1%	Shares	Other	2026-02-13
2025-09-30	$1,293,736	88,370	+112.9%	Shares	Other	2025-11-14
2025-06-30	$641,620	41,502	+86.8%	Shares	Other	2025-08-14
2025-03-31	$330,441	22,222	+4.6%	Shares	Other	2025-05-14
2024-12-31	$281,230	21,241	+86.9%	Shares	Other	2025-02-03
2024-09-30	$161,638	11,367	+4.0%	Shares	Other	2024-11-14
2024-06-30	$141,421	10,929	—	Shares	Other	2024-08-12
No filing history on record for this holder in this stock.